Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / RVMD - Revolution Medicines GAAP EPS of -$0.63 beats by $0.18 revenue of $15.33M beats by $7.53M

RVMD - Revolution Medicines GAAP EPS of -$0.63 beats by $0.18 revenue of $15.33M beats by $7.53M

Revolution Medicines Inc.
  • Revolution Medicines press release ( NASDAQ: RVMD ): Q4 GAAP EPS of -$0.63 beats by $0.18 .
  • Revenue of $15.33M (+62.1% Y/Y) beats by $7.53M .

  • Financial Guidance

  • Revolution Medicines expects full year 2023 GAAP net loss to be between $335 and $365 million, which includes estimated non-cash stock-based compensation expense of $40 million and $50 million.

For further details see:

Revolution Medicines GAAP EPS of -$0.63 beats by $0.18, revenue of $15.33M beats by $7.53M
Stock Information
Company Name: Revolution Medicines Inc.
Stock Symbol: RVMD
Market: NASDAQ
Website: revmed.com
Menu
RVMD RVMD Quote RVMD Short RVMD News RVMD Articles RVMD Message Board
Get RVMD Alerts

News, Short Squeeze, Breakout and More Instantly...